Over‐activation of mGluR5 is reported to be associated with cognitive impairment in APP/PS1 male mice (Hamilton et al., 2016), and excessive mGluR5 signalling activation is restricted to early stages of the disease (Abd‐Elrahman et al., 2020). The gene discussed is APP; the disease is Cognitive impairment.